The A45 tumor treatment is based on the difference in the photosynthetic absorption rate and the metabolic rate in the tumor cells and the normal cells (the absorption rate of the drug in cancer cells 10 times to 20 times) It is a treatment to kill cancer cells only by reacting. The A45 medical electron accelerator is a way in which the X-ray of 45MV reacts with the photosensitizer. A45 Tumor therapy technology is attracting attention as a new treatment in the 21st century. This treatment can be widely used to treat serious bacterial infections, hemangiomas, viral diseases.

A45 tumor treatment uses a photoinitiator to activate the cancer-cell-associated cells through the A45 X-ray, targeting the photosensitized photosensitized tumor cells, and the resulting linear oxygen (102) It will kill the cells. This technology is a photon missile, and it can be regarded as a kind of target treatment because of the explosion of cancer cells induced by light miner drug. It can be applied to other metastatic tumors by eliminating molecular lesions and cancer cells.

1. Dual targets can be applied. The combination of radiotherapy and drug targets precisely target cancerous nuclides and induce lesion infiltration (10 times to 20 times).

2. Molecular Targeting: Kill a target in molecular units with the correct target. The resulting 102 (linear oxygen material) will be self destructed with a cell of molecular unit 10 to 20 mm near the target.

3. High-efficiency action: (linear oxygen material) 102 occurs only in target cells.

4. Continuous action: The effect of molecular killing will be as small as a domino action initiated via the A45 X-ray.

1 Low efficacy versus low efficacy: Conventional anticancer drugs are toxic and kill both cancer cells and normal tissue cells, whereas A45 tumor treatment is non-toxic to its own drugs and is absorbed only by cancer cells,

2. Binding to lesion cells (cancer cells): Conventional anticancer drugs only responded to specific or selective tissues. However, the A45 tumor treatment drug is characterized by its ability to respond only to molecular targets and cancer cell surfaces.

3. There is a tumor effect in the third, fourth, or last stage patients.

If you have metastatic cancer, it may not be effective for general treatment. Therefore, A45 treatment has become effective as a non-toxic drug and target treatment that is activated only in cancer cells.

4. No tumor resistance.

Existing chemotherapy produces toxic compounds of drugs, and cancer cells are resistant to those toxic compounds. Chemotherapy is no longer effective and cancer cells multiply again. A45 therapy is non-toxic and does not cause resistance or resistance to cancer cell responses.

A45 The tumor treatment drug changes the energy in the cell to necrotize the cancer cell and necrotize the tumor cell, and actively respond to the cancer cell which was originally difficult to treat by conventional radiation therapy or chemotherapy.

1. This treatment is good for tumor cells. Since the target of targeting only cancer cells is large, the side effects on normal cells are small and the treatment effect is great.

2. By combining both the systemic action of existing chemotherapy and the local treatment of radiation therapy, you can achieve a 1 + 1 effect. Taking advantage of these two treatments, it is equally valid for local and systemic lesions (metastatic).

3. The amino acid used is used as a means of synthesis of the body's synthetic minerals, which has a high binding activity to the underlying lesions and has a very high target orientation. At the same time, the amino acids themselves act without toxicity.

4. In-body synthetic dyes are stimulated only by the A45 X-ray and have a chemical half, without any toxic side effects. Inside the lesion cells, high-grade linear oxygen (102) is generated to destroy cancer cells.

5. Stimulates with very low energy photon doses (4 to 5 Gy) and is only 1 / 10th of conventional radiation therapy, so radiation-induced complications do not occur.

6. Therapy cycle is short, it can be repeatedly used, and it can be used with conventional chemotherapy.

7. It is applicable to the treatment of malignant tumors of various carcinomas, especially stage 3, stage 4 or terminally ill patients.

 A45 We have seen that target therapy treats small cell cancer. This treatment is one of the relatively stable treatments. This new treatment will be applied to many malignant tumors in the future and will be secured through many clinical studies.

HK HIS will try to keep your health with the best technology.